ArticleCureus2025
Echocardiographic Assessment of Structural and Functional Cardiac Alterations in Gestational Hypertension and Preeclampsia: A Comparative Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Hypertensive disorders of pregnancy (HDP), encompassing gestational hypertension and preeclampsia, are significant cardiovascular complications and leading causes of maternal morbidity and mortality. These conditions involve complex pathophysiological mechanisms extending beyond elevated blood pressure and induce cardiac structural and functional adaptations with potential long-term cardiovascular implications. Contemporary evidence demonstrates that women with hypertensive pregnancy disorders face substantially elevated risks for future cardiovascular disease. This comparative cross-sectional investigation aimed to systematically evaluate echocardiographic differences between pregnant women with gestational hypertension/preeclampsia and normotensive controls, providing a detailed characterization of cardiac structural and functional parameters to inform obstetric practice. Methodology This cross-sectional study was conducted at the Department of Obstetrics and Gynecology, Government Kilpauk Medical College, Chennai, following institutional ethics approval (IEC.NO-317/2020) with written informed consent. The investigation included 80 pregnant women aged 18-34 years in the third trimester, equally allocated into hypertensive (n=40) and normotensive control (n=40) groups through systematic age and parity matching. Inclusion criteria encompassed pregnant patients with systolic blood pressure ≥140 mmHg and diastolic blood pressure ≥90 mmHg developing after 20 weeks of gestation. Comprehensive echocardiographic assessment was performed using standardized protocols, evaluating left ventricular morphology, systolic function, diastolic performance, left atrial volumetric measurements, and pulmonary hemodynamics. Results Demographic characteristics demonstrated successful matching between groups (age: 25.55 vs 25.88 years, p=0.753; parity distribution: p=0.263). Proteinuria assessment showed 85% of hypertensive patients versus 5% of controls with a protein-to-creatinine ratio ≥0.3 (p<0.001). Left ventricular structural analysis revealed significant chamber dilatation in hypertensive patients (left ventricular end-diastolic diameter (LVEDD): 50.75 vs 41.60 mm, p<0.001; left ventricular end-systolic diameter (LVESD): 34.48 vs 26.83 mm, p<0.001) with adaptive wall thickening (left ventricular posterior wall systolic (LVPWs): 1.16 vs 0.95 mm, p<0.001). Diastolic function assessment demonstrated impaired relaxation patterns, including a reduced E/A ratio (1.31 vs 1.51, p=0.010), elevated E/e' ratio (9.05 vs 7.63, p<0.001), and prolonged mitral valve deceleration time (144.50 vs 123.35 ms, p<0.001). Left atrial volumetric analysis revealed substantial enlargement (left atrial volume index (LAVI): 31.52 vs 17.56 mL/m², p<0.001). Pulmonary artery systolic pressure was significantly elevated (18.70 vs 16.93 mmHg, p<0.001), while systolic function remained preserved (ejection fraction: 67.23% vs 65.15%, p=0.311). Conclusion This echocardiographic investigation demonstrates significant cardiac structural and functional alterations in gestational hypertension and preeclampsia, characterized by ventricular remodeling, diastolic dysfunction, and pronounced left atrial enlargement. These findings highlight cardiac adaptations in hypertensive pregnancy disorders that warrant further multicenter investigation to determine clinical applications for screening and risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.